Health TrialsbyHealthPanel

Building Retention and Initiation Through Delivery of Peer-Guided Evidence-Based Practices

ConditionOpioid Use Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPrisma Health-Upstate

About this trial

This study will provide longitudinal data for 6-months on a target sample of patients with Opioid Use Disorder (OUD) recruited from Prisma Health Mobile Health Clinics in South Carolina. The goal of our study is to increase OUD treatment initiation and retention and maximize prevention of overdose deaths in underserved communities through development, testing, and delivery of a novel intervention targeting areas of optimal allocation of MHC with a Peer Support Specialist (PSS) intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18+

Have diagnosis of OUD

New mobile health MOUD patient

Disqualifiers

Unable to read and comprehend the consent materials and other study materials

Currently working with a Certified Peer Support Specialist

Having severe medical or psychiatric disability that would hinder participation in the study, as determined by the clinical provider

Trial design

Design model

Parallel

Treatments tested in this trial

  • Certified Peer Support Specialist Intervention

    Behavioral

    Participants are recruited from mobile health clinics (MHC) delivered to communities using a predictive modeling framework to target areas for optimal MHC allocation to maximize prevention of overdose deaths. Patients randomized to the intervention arm are linked to a peer support specialist. Peer support specialists are Certified Peer Support Specialists (CPSS) who have lived experience with Opioid Use Disorder (OUD) and OUD recovery. Peer support specialists offer consistent personalized recovery support and generalized social support based on a peer support checklist. Peer support specialists will maintain contact and provide support for the participant for 6 months post-baseline, following a peer support manual.

Treatment groups

750 Participants
are divided into 2 treatment groups
Group A: Standard of CareNo intervention 0 interventions
Group B: Certified Peer Intervention SpecialistExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Medications for Opioid Use Disorder (MOUD) Initiation

MOUD initiation defined as receipt of first MOUD prescription within 3 months since baseline assessment.

Time frame
3 months
2

Medications for Opioid Use Disorder (MOUD) Retention

MOUD retention at 6 months defined as receipt of 80% of MOUD prescriptions in first 6 months since baseline assessment.

Time frame
6 months

Secondary outcomes

1

Adherence to Buprenorphine

Medication Adherence Self-Report Inventory (MASRI)

Time frame
Weekly; 24 weeks
2

Barriers to Healthcare

Social Determinations of Health (SDOH)

Time frame
90 days
3

Frequency of Opioid Use

Addiction Severity Index (ASI-Lite) 0-1: No imminent problem, treatment not indicated. 2-3: Slight problem; treatment may not be necessary. 4-5: Moderate problem, a treatment plan should be considered. 6-7: Considerable difficulty, begin a treatment plan. 8-9: Extreme problem, treatment is vital.

Time frame
Monthly; 24 weeks
4

Overdose

Questionnaire

Time frame
Weekly; 24 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Prisma Health-Upstate

Lead sponsor

Clemson University

Collaborator

Source ClinicalTrials.gov
Apply now